
Novel Platform: AVIDIO
- RNA-based artificial virus vaccine and immunotherapy platform
- High payload capacity for delivering multiple transgenes
- Broad spectrum of immune responses
- High potential for oncology and infectious diseases

AVIDIO Platform
(Artificial Virus for Infectious Diseases and Immuno-Oncology) Patented. Worldwide exclusive rights from Yale University